Taro Pharmaceutical Industries is a multinational, science-based pharmaceutical company. Co. develops, manufactures and markets prescription and over-the-counter pharmaceutical products mainly in the U.S., Canada and Israel. Co.'s main focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Co. manufactures finished dosage form pharmaceutical products for sale in Israel and for export; and produces active pharmaceutical ingredients used in the manufacture of finished dosage form pharmaceutical products. The TARO YTD return is shown above.
The YTD Return on the TARO YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether TARO YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the TARO YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|